Tacrolimus and Intron a drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Intron a (interferon alfa-2b). Common drug interactions include anaemia among females and lymph node tuberculosis among males.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Intron a. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

On Jul, 18, 2026

13 people who take Tacrolimus and Intron a together, and have interactions are studied.

Tacrolimus and Intron a drug interactions.

What are the common drug interactions of Tacrolimus and Intron A, by gender? *:

female:

Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Drug ineffective
Drug level increased
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Neutropenia (an abnormally low number of neutrophils)
Hepatic enzyme increased
Hepatitis c
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Renal impairment (severely reduced kidney function)

male:

Lymph node tuberculosis
Anaemia (lack of blood)
Sialoadenitis (inflammation of a salivary gland)
Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
Gamma-glutamyltransferase increased
Hypotension (abnormally low blood pressure)
Liver transplant rejection (failure of liver transplant)
Drug ineffective
Dry mouth
Myelopathy (any neurologic deficit related to the spinal cord)

What are the common drug interactions of Tacrolimus and Intron A, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Drug ineffective
Drug level increased
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Neutropenia (an abnormally low number of neutrophils)
Hepatic enzyme increased
Hepatitis c
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Renal impairment (severely reduced kidney function)

40-49:

n/a

50-59:

Hypotension (abnormally low blood pressure)
Liver transplant rejection (failure of liver transplant)
Alanine aminotransferase increased
Balance disorder
Blood alkaline phosphatase increased
Blood bilirubin increased
Cerebellar ataxia (loss of coordination)
Dysarthria (speech disorder)
Hearing impaired
Intention tremor (brain tremor)

60+:

Drug ineffective
Dry mouth
Myelopathy (any neurologic deficit related to the spinal cord)
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Pyramidal tract syndrome (disorder characterized by dysfunction of the corticospinal (pyramidal) tracts of the spinal cord)
Sialoadenitis (inflammation of a salivary gland)
Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)

What are the existing conditions these people have? *

Hepatitis C: 5 people, 38.46%
St. Louis Encephalitis (a disease caused by the culex mosquito borne saint louis encephalitis virus affects brain): 2 people, 15.38%
Hepatitis Cholestatic (flow of bile from the liver is slowed or blocked): 2 people, 15.38%
West Nile Viral Infection: 1 person, 7.69%
Skin Cancer: 1 person, 7.69%
Immunodeficiency Disorders: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Intron a?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously